Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data

A. N. KULIKOV, N. V. MURAVYEVA, B. S. BELOV

Open source

DOI
10.37489/0235-2990-2022-67-7-8-33-39
Published
2022-11-16
Container
Antibiotics and Chemotherapy
Publisher
Publishing House OKI
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.37489/0235-2990-2022-67-7-8-33-39,
  title = {Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data},
  author = {A. N. KULIKOV and N. V. MURAVYEVA and B. S. BELOV},
  year = {2022},
  journal = {Antibiotics and Chemotherapy},
  doi = {10.37489/0235-2990-2022-67-7-8-33-39},
  url = {https://doi.org/10.37489/0235-2990-2022-67-7-8-33-39}
}

RIS

TY  - JOUR
TI  - Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data
AU  - A. N. KULIKOV
AU  - N. V. MURAVYEVA
AU  - B. S. BELOV
PY  - 2022
JO  - Antibiotics and Chemotherapy
DO  - 10.37489/0235-2990-2022-67-7-8-33-39
UR  - https://doi.org/10.37489/0235-2990-2022-67-7-8-33-39
ER  - 

APA

KULIKOV, A. N., MURAVYEVA, N. V., & BELOV, B. S. (2022). Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data. Antibiotics and Chemotherapy. https://doi.org/10.37489/0235-2990-2022-67-7-8-33-39

Source records